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Background: Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) persist in the
environment and are found in relatively high concentrations in animal livers. Studies in humans
have reported inconsistent associations between PFOA and liver enzymes.
Objectives: We examined the cross-sectional association between serum PFOA and PFOS concentrations with markers of liver function in adults.
Methods: The C8 Health Project collected data on 69,030 persons; of these, a total of 47,092
adults were included in the present analysis. Linear regression models were fitted for natural log
(ln)-transformed values of alanine transaminase (ALT), γ-glutamyltransferase (GGT), and direct
bilirubin on PFOA, PFOS, and potential confounders. Logistic regression models were fitted
comparing deciles of PFOA or PFOS in relation to high biomarker levels. A multilevel analysis
comparing the evidence for association of PFOA with liver function at the individual level within
water districts to that at the population level between water districts was also performed.
Results: ln-PFOA and ln-PFOS were associated with ln-ALT in linear regression models [PFOA:
coefficient, 0.022; 95% confidence interval (CI): 0.018, 0.025; PFOS: coefficient, 0.020; 95% CI:
0.014, 0.026] and with raised ALT in logistic regression models [with a steady increase in the odds
ratio (OR) estimates across deciles of PFOA and PFOS; PFOA: OR = 1.10; 95% CI: 1.07, 1.13;
PFOS: OR = 1.13; 95% CI: 1.07, 1.18]. There was less consistent evidence of an association of
PFOA and GGT or bilirubin. The relationship with bilirubin appears to rise at low levels of PFOA
and to fall again at higher levels.
Conclusions: These results show a positive association between PFOA and PFOS concentrations
and serum ALT level, a marker of hepatocellular damage.
Key words: C8, cross-sectional study, liver function biomarkers, PFOA, PFOS, population-based
survey. Environ Health Perspect 120:655–660 (2012). http://dx.doi.org/10.1289/ehp.1104436
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Perfluorooctanoate (PFOA) and perfluoro
octane sulfonate (PFOS) are two members
of the perfluoroalkyl acid (PFAA) class of
chemicals, man-made compounds used in
the manufacture of fluoropolymers, including
those used for nonstick cookware and breath
able, waterproof fabrics. PFOA and PFOS can
also result from the metabolism of fluorinated
telomers, compounds used for food package
coatings, carpet treatments, and stain-resistant
fabric treatment. PFOA and PFOS persist in
the environment (Kato et al. 2011; Tao et al.
2006); potential sources of exposure to PFOA
and PFOS in humans include drinking water,
dust, breast milk, food packaging, ambient
air, and occupation (D’Hollander et al. 2010;
Goosey and Harrad 2011; Kim et al. 2011;
Lau et al. 2007).
In rodents and nonhuman primates, both
PFOA and PFOS have been found in relatively
high concentrations in the liver and have been
associated with liver enlargement. In rats, these
compounds have been also associated with
hepatocellular adenomas (Lau et al. 2007). In
mice, one of the biological effects of PFAAs is
Environmental Health Perspectives •

volume

the activation of the peroxisome proliferatoractivated receptor-α (PPAR-α), a ligandactivated transcription factor that regulates gene
expression, lipid modulation, glucose homeo
stasis, cell proliferation, and inflammation
(Pyper et al. 2010). Although some effects in
experimental studies are mediated by PPAR-α
binding, some other effects occur indepen
dently of this receptor (Bjork et al. 2011; Ren
et al. 2009). PPAR-α is also induced by PFOA
and PFOS in transiently transfected human
fibroblast-like cell line COS-1, in a concentra
tion-dependent and in a roughly chain-length–
dependent fashion (Wolf et al. 2008).
Studies in humans have reported incon
sistent associations between PFOA or PFOS
and liver enzymes. Transaminase levels have
been positively associated with PFOA con
centrations in some occupational studies
(Costa et al. 2009; Olsen and Zobel 2007;
Sakr et al. 2007b) but not in others (Costa
et al. 2009; Sakr et al. 2007b). Similarly,
γ-glutamyltransferase (GGT) levels have been
inconsistently associated with PFOA concen
trations in occupational studies (Costa et al.
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2009; Olsen and Zobel 2007; Sakr et al.
2007a, 2007b). In a large population-based
survey, PFOA but not PFOS was associated
with both transaminase and GGT levels (Lin
et al. 2010), although those findings differed
from those of an earlier, much smaller popula
tion-based study of subjects heavily exposed to
PFOA (Emmett et al. 2006). Direct bilirubin
has been found to be negatively associated with
PFOA concentrations in a few occupational
studies (Costa et al. 2009; Olsen and Zobel
2007; Sakr et al. 2007b) but not in others
(Costa et al. 2009; Sakr et al. 2007a). No asso
ciation between direct bilirubin and PFOA or
PFOS was observed in population-based stud
ies (Emmett et al. 2006; Lin et al. 2010).
From 1950 through 2005, a chemical plant
in the Mid-Ohio Valley, West Virginia (USA),
was responsible for emitting PFOA into the
surrounding environment. In 2001, a group
of residents filed a class action lawsuit alleging
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health damage from the drinking water sup
plies drawing on PFOA-contaminated ground
water (Frisbee et al. 2009). Part of the pretrial
settlement of the class action lawsuit included
a baseline survey, the C8 Health Project, con
ducted in 2005–2006, that gathered data from
> 69,000 persons from six contaminated water
districts surrounding the plant (Frisbee et al.
2009). In this population, overall PFOA lev
els were much higher [mean, 83.0 ng/mL;

interquartile range (IQR), 13.4–70.6 ng/mL]
than in corresponding U.S. population surveys
(National Health and Nutrition Examination
Survey in the same year: mean, 3.9 ng/mL;
IQR, 2.7–5.8 ng/mL) (Frisbee et al. 2009;
Kato et al. 2011). However, the mean PFOS
(23.3 ng/mL; IQR, 13.8–29.0 ng/mL)
closely resembled the U.S. population mean
(20.7 ng/mL; IQR, 14.6–29.9 ng/mL) (Kato
et al. 2011). The present study used these

Table 1. Participant characteristics, Mid-Ohio Valley, 2005–2006.
Characteristic
Women (n = 24,171)
Age (median/mean ± SD)
44.3/45.1 ± 15.9
Regular exercise [n (%)]
7,821 (32.4)
BMI [n (%)]
Underweight
471 (2.0)
Normal weight
8,236 (34.1)
Overweight
6,848 (28.3)
Obese, class I
4,545 (18.8)
Obese, class II
2,257 (9.3)
Obese, class III
1,814 (7.5)
Household income, US$/year [n (%)]
≤ 10,000
2,852 (11.8)
10,001–20,000
4,127 (17.1)
20,001–30,000
3,899 (16.1)
30,001–40,000
3,340 (13.8)
40,001–50,000
2,690 (11.1)
50,001–60,000
2,207 (9.1)
60,001–70,000
1,736 (7.2)
> 70,000
3,320 (13.7)
Education [n (%)]
< 12 years
2,630 (10.9)
High school diploma or GED
9,453 (39.1)
Some college
8,760 (36.2)
≥ Bachelor degree
3,328 (13.8)
Race [n (%)]
White
23,531 (97.4)
Black
209 (0.9)
Other
431 (1.8)
Alcohol consumption [n (%)]
None
13,487 (55.8)
< 1 drink/month
5,251 (21.7)
< 1 drink/week
2,797 (11.6)
Few drinks/week
2,209 (9.1)
1–3 drinks/day
336 (1.4)
> 3 drinks/day
91 (0.4)
Smoking status [n (%)]
Never
12,775 (52.9)
Former
5,178 (21.4)
Current < 10 cigarettes/day
2,836 (11.7)
Current 10–19 cigarettes/day
2,285 (9.5)
Current ≥ 20 cigarettes/day
1,097 (4.5)
ALT (IU/L)
Median/mean ± SD
17.0/20.8 ± 16.0
≤ 45 (m), ≤ 34 (w) [n (%)]
22,088 (91.4)
> 45 (m), > 34 (w) [n (%)]
2,083 (8.6)
GGT (IU/L)
Median/mean ± SD
17.0/24.3 ± 31.0
≤ 55 (m), ≤ 38 (w) [n (%)]
21,243 (87.9)
> 55 (m), > 38 (w) [n (%)]
2,928 (12.1)
Direct bilirubin (mg/dL)
Median/mean ± SD
0.1/0.1 ± 0.4
≤ 0.3 [n (%)]
24,045 (99.5)
> 0.3 [n (%)]
126 (0.5)
PFOA, ng/mL [median (IQR)]
23.1 (11.3–58.2)
PFOS, ng/mL [median (IQR)]
17.4 (11.6–25.5)

Men (n = 22,281)
45.5/45.8 ± 15.8
6,741 (30.3)

Total (n = 46,452)
44.7/45.5 ± 15.9
14,562 (31.4)

p-Valuea
< 0.001
< 0.001

153 (0.7)
5,156 (23.1)
9,339 (41.9)
5,066 (22.7)
1,753 (7.9)
814 (3.7)

624 (1.3)
13,392 (28.8)
16,187 (34.9)
9,611 (20.7)
4,010 (8.6)
2,628 (5.7)

< 0.001

2,081 (9.3)
3,018 (13.6)
3,636 (16.3)
3,265 (14.7)
2,664 (12.0)
2,277 (10.2)
1,817 (8.2)
3,523 (15.8)

4,933 (10.6)
7,145 (15.4)
7,535 (16.2)
6,605 (14.2)
5,354 (11.5)
4,484 (9.7)
3,553 (7.7)
6,843 (14.7)

< 0.001

2,623 (11.8)
9,935 (44.6)
6,723 (30.2)
3,000 (13.5)

5,253 (11.3)
19,388 (41.7)
15,483 (33.3)
6,328 (13.6)

< 0.001

21,685 (97.3)
245 (1.1)
351 (1.6)

45,216 (97.3)
454 (1.0)
782 (1.7)

0.009

9,968 (44.7)
3,128 (14.0)
2,717 (12.2)
4,630 (20.8)
1,225 (5.5)
613 (2.8)

23,455 (50.5)
8,379 (18.0)
5,514 (11.9)
6,839 (14.7)
1,561 (3.4)
704 (1.5)

< 0.001

9,489 (42.6)
6,998 (31.4)
1,900 (8.5)
2,124 (9.5)
1,770 (7.9)

22,264 (47.9)
12,176 (26.2)
4,736 (10.2)
4,409 (9.5)
2,867 (6.2)

< 0.001

26/31.0 ± 22.5
19,170 (86.0)
3,111 (14.0)

21.0/25.7 ± 20.1
41,258 (88.8)
5,194 (11.2)

< 0.001
< 0.001

27.0/37.5 ± 53.5
19,219 (86.3)
3,062 (13.7)

21.0/30.7 ± 43.7
40,462 (87.1)
5,990 (12.9)

< 0.001
< 0.001

0.1/0.1 ± 0.6
21,901 (98.3)
380 (1.7)
34.3 (16.6–85.1)
23.5 (16.8–32.6)

0.1/0.1 ± 0.6
45,946 (98.9)
506 (1.1)
28.0 (13.5–70.8)
20.3 (13.7–29.4)

< 0.001
< 0.001
< 0.001
< 0.001

Abbreviations: m, men; w, women.
ap-Value for chi-square test for categorical variables, and t-test for continuous variables–based testing the difference
between sexes.
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data to examine the cross-sectional association
between serum PFOA or PFOS concentrations
and markers of liver function in adults.

Methods
The study population. This study was approved
by the London School of Hygiene and Tropical
Medicine Ethics Committee and is one of the
C8 Science Panel studies and used information
from questionnaires and blood tests collected
in the C8 Health Project, supplemented by
further information on classification by water
district developed in a companion C8 Science
Panel study (Shin et al. 2011).
The C8 Health Project enrolled eligible
subjects between August 2005 and August
2006. Individuals were eligible to partici
pate if they had consumed water for at least
1 year between 1950 and 2004 while living,
working, or going to school in one of the six
water districts, or private water sources, or
areas of documented PFOA contamination.
The between- and within-group regression
analysis was restricted to subjects living in one
of the six contaminated water districts at the
time of survey [for additional details on water
districts, see Supplemental Material (http://
dx.doi.org/10.1289/ehp.1104436)]. Details
of the study enrollment process, including
consenting procedures, have been described
elsewhere (Frisbee et al. 2009).
The C8 Health Project collected data on
69,030 persons. Its participation rate, based
on U.S. census numbers, has been estimated
at around 80% (Frisbee et al. 2009). In this
population, the strongest predictor of PFOA
serum concentration was residence in one of the
contaminated water districts (Steenland et al.
2009), whereas serum levels of other PFAAs
did not show such geographic variation. Of the
population, 56,554 adults (≥ 18 years of age)
were considered for this analysis, and a total of
46,452 of those adults (82.1%) were included
in the final analysis after exclusion of subjects
with missing data on socioeconomic status,
alcohol consumption, or cigarette smoking
or other potential confounding variables or
without PFAAs or liver enzymes measurements.
Choice of parameters and laboratory analyses. Blood samples were obtained and processed
at individual data collection sites. Samples were
drawn into four tubes per participant, with a
maximum of 35 mL blood collected. Samples
were centrifuged, aliquoted, and refrigerated
until shipping. Processed samples were shipped
on dry ice daily from each data collection site to
the laboratory (Frisbee et al. 2009). Participants
were not asked to fast before blood sample
withdrawal, but fasting status was recorded.
Laboratory analyses of PFAAs were con
ducted by the Exygen Research Inc. (State
College, PA, USA). using an automated solidphase extraction combined with reverse-phase
high-performance liquid chromatography/
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mass spectrometry (Kuklenyik et al. 2004). An
intralaboratory quality assurance program was
carried out by analysis of duplicate samples
at AXYS Analytical Service Ltd. (Sidney, BC,
Canada) (Frisbee et al. 2009). The intralabora
tory coefficient of variation for both PFOA
and PFOS measurements was 0.1; the inter
laboratory comparison coefficient of varia
tion was 0.2 for PFOA and 0.1 for PFOS
(Frisbee et al. 2009). The detection limit was
0.5 ng/mL for both PFOA and PFOS, and
observations below this limit were assigned a
value of 0.25 ng/mL (for this study popula
tion, n = 32 for PFOA, n = 230 for PFOS).
Both PFOA and PFOS concentration distri
butions were skewed to the right.
The liver parameters we measured were
alanine aminostransferase (ALT) and aspartate
aminostransferase (AST), GGT, alkaline phos
phatase (ALP), and direct bilirubin (also known
as “conjugated bilirubin”). Both transaminases
(AST and ALT) are enzymes released after liver
parenchymal cell injury and are elevated in
serum during acute liver damage; the correla
tion between ALT and AST in the present
population is r = 0.79. To limit multiple com
parisons and to be consistent with the most
recent published literature on the same topic
(Lin et al. 2010), we restricted our analysis to
ALT, GGT, and direct bilirubin as markers
of liver function. Elevated ALT has been used
as a proxy for hepatocellular injury in previous
studies (Clark et al. 2003; Ioannou et al. 2005;
Lin et al. 2010; Ruhl and Everhart 2003)
because it is more specific for hepatic damage
than is AST. Elevation of GGT occurs at an
early stage and is more persistent than that of
ALP in cholestatic disorders (Whitfield 2001);
the correlation between GGT and ALP in the
present population was r = 0.29. Bilirubin is
mostly derived from the metabolism of hemo
globin; the increase in serum of the direct bili
rubin component is highly specific for liver or
bile duct disease (Sedlak and Snyder 2004).
ALT, GGT, and direct bilirubin were
measured using a Roche/Hitachi MODULAR
automated analyzer (Roche Diagnostics,
Indianapolis, IN, USA), and the analyses were
performed at a large, independent, accredited
clinical diagnostic laboratory (LabCorp, Inc.,
Burlington, NC, USA) (Frisbee et al. 2009).
The homeostasis model assessment of insulin
resistance (HOMA-IR) index was calculated as
the product of basal glucose and insulin levels
divided by 2.25; it is used as a surrogate measure
for insulin resistance (Matthews et al. 1985).
Methods and results are described accord
ing to the STrengthening the Reporting of
OBservational studies in Epidemiology—
Molecular Epidemiology (STROBE-ME)
guidelines (Gallo et al. 2011).
Statistical analysis. Distributions of con
tinuous variables were inspected, and all
three outcome markers were natural log (ln)
Environmental Health Perspectives •
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transformed for linear regression models. We
investigated univariate associations between
exposure (serum concentration of PFOA
and PFOS), liver function biomarkers (ALT,
GGT, direct bilirubin), and potential con
founders: age, physical activity, body mass
index (BMI; classified as underweight/normal
weight/overweight, obese class I/II/III), aver
age household income (≤ $10,000, $10,001–
20,000, $20,001–30,000, $30,001–40,000,
$40,001–50,000, $50,001–60,000, $60,001–
70,000, > $70,000), educational level [high
school diploma or general educational devel
opment (GED), some college, bachelor degree
or higher], race (white, black, other), alcohol
consumption (none, < 1 drink/month, < 1
drink/week, few drinks/week, 1–3 drinks/day,
> 3 drinks/day) and cigarette smoking (never
smoker, former, current < 10 cigarettes/day,
current 10–19 cigarettes/day, current ≥ 20
cigarettes/day).
The association between ALT, GGT,
or direct bilirubin and PFOA or PFOS was
assessed using linear regression models. First,
we fitted a simple model including only
age and sex (model 1), followed by a model
additionally including alcohol consumption,
socioeconomic status, fasting status, race, and
month of blood sample collection (model 2),
and then a model additionally including
smoking status, BMI, physical activity, and
insulin resistance (i.e., HOMA-IR) in deciles
of distribution (model 3).
Also, specific cutoff values were used to
fit logistic regression models to estimate the
impact of PFOA and PFOS on being above
these values. Cutoff values used were 45 IU/L
in men and 34 IU/L in women for ALT
(Schumann et al. 2002a), giving a total of
5,194 persons (11.2% of the 47,092 eligible
participants) with above-normal values;
55 IU/L in men and 38 IU/L in women
for GGT (Schumann et al. 2002b), giving
5,990 persons (12.9%) with above-normal
values; and 0.3 mg/dL in men and women for

direct bilirubin (Kratz et al. 2004), giving 506
persons (1.1%) with above-normal values.
Prior research showed that individual
serum levels of PFOA were strongly associated
with the water district of residence (Steenland
et al. 2009). This geographic clustering implies
a potential for an ecological confounding by
other uncontrolled and/or unobserved water
district–specific factors. On the other hand,
there is also potential for confounding at the
individual level. We expect a priori some
heterogeneity in between- and within-group
relationships; therefore, we applied an ana
lytic approach in the multilevel framework
[between- and within-group regression (Davis
et al. 1961)] to disentangle between- and
within-district effects of PFOA. In statisti
cal modeling, this is realized by simultane
ously incorporating both individual PFOA
serum concentrations and the means of PFOA
within water districts. Details of this analy
sis are reported in the Supplemental Material
(http://dx.doi.org/10.1289/ehp.1104436).

Results
General characteristics of the population are
summarized in Table 1. Women had sig
nificantly lower values of liver function bio
markers and of PFOA and PFOS. PFOA and
PFOS concentrations were associated with all
potential confounders considered.
ln-Transformed values of ALT were signifi
cantly associated with ln-PFOA and ln-PFOS in
linear regression models [fully adjusted (model
3) coefficient: PFOA, 0.022; 95% confidence
interval (CI): 0.018, 0.025; PFOS, 0.020; 95%
CI: 0.014, 0.026], with a partial R2 greater for
the association with PFOA (partial R2 = 0.002)
than for that with PFOS (partial R2 < 0.001;
Table 2). In Figure 1, mean ALT levels are plot
ted against deciles of PFOA and PFOS concen
trations, adjusting for covariates by setting these
to their means. A steady increase in fitted levels
of ALT per decile of PFOA is shown, with a
possible leveling off effect after approximately

Table 2. Linear regression coefficients of ln-transformed blood analytes with a one-unit increase in
ln-PFOA and ln-PFOS concentrations.
ln-PFOA
Liver function biomarker
ln-ALT
Model 1b
Model 2c
Model 3d
ln-GGT
Model 1b
Model 2c
Model 3d
ln-Direct bilirubin
Model 1b
Model 2c
Model 3d

Coefficient (95% CI)

ln-PFOS
R 2 (partial R 2)a

Coefficient (95% CI)

R 2 (partial R 2)a

0.029 (0.023, 0.036)**
0.026 (0.020, 0.033)**
0.020 (0.014, 0.026)**

0.170 (0.002)
0.175 (0.002)
0.263 (< 0.001)
0.145 (< 0.001)
0.166 (< 0.001)
0.248 (< 0.001)

0.018 (0.014, 0.021)**
0.014 (0.010, 0.018)**
0.022 (0.018, 0.025)**

0.170 (0.002)
0.174 (0.001)
0.265 (0.002)

0.005 (–0.0001, 0.009)
0.004 (–0.001, 0.009)
0.015 (0.010, 0.019)**

0.145 (< 0.001)
0.166 (< 0.001)
0.249 (0.001)

–0.008 (–0.016, –0.001)
0.006 (–0.002, 0.014)
0.008 (–0.0002, 0.016)

0.004 (0.001, 0.007)*
0.003 (0.0004, 0.006)*
0.001 (–0.002, 0.004)

0.094 (< 0.001)
0.121 (< 0.001)
0.163 (< 0.001)

0.033 (0.028, 0.039)**
0.034 (0.029, 0.040)**
0.029 (0.024, 0.034)**

0.097 (0.003)
0.124 (0.003)
0.166 (0.003)

R2, difference between R2 including and excluding PFOA or PFOS in the model. bAdjusted for age and sex.
for alcohol consumption, socioeconomic status, fasting status, race, and month of blood sample collection in
addition to adjustment in model 1. dAdjusted for smoking status, BMI, physical activity, and insulin resistance in addition
to adjustment in model 2. *p < 0.05. **p < 0.001.

aPartial

cAdjusted
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and PFOS (p-value for trends across deciles in
both models < 0.001), and a significant OR for
both ln-unit of PFOA (OR = 1.10; 95% CI:
1.07, 1.13) and ln-unit of PFOS (OR = 1.13;
95% CI: 1.07, 1.18; Table 3). Subjects with
abnormally high ALT values were evenly

24
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23

ALT (IU/L)

ALT (IU/L)

30 ng/mL. A comparable distribution is observ
able for PFOS, although in a narrower range
of exposure (Figure 1A,B). This positive asso
ciation was also observed in logistic regression
models with a steady increase in the odds ratio
(OR) estimates across deciles of both PFOA

22

21

22

21

20

20
5

10

20

40

80

160

320

640

5

10

26

26

25

25

24

24

23
22

40

80

160

320

640

320

640

320

640

23
22

21

21
5

10

20

40

80

160

320

640

5

10

Decile of PFOA (ng/mL)

20

40

80

160

Decile of PFOS (ng/mL)

0.114

0.114

0.112

0.112

Direct bilirubin (mg/dL)

Direct bilirubin (mg/dL)

20

Decile of PFOS (ng/mL)

GGT (IU/L)

GGT (IU/L)

Decile of PFOA (ng/mL)

0.110
0.108
0.106
0.104
0.102

0.010
0.108
0.106
0.104
0.102

5

10

20

40

80

160

320

640

Decile of PFOA (ng/mL)

5

10

20

40

80

160

Decile of PFOS (ng/mL)

Figure 1. Fitted values of ALT (A,B), GGT (C,D), and direct bilirubin (E,F) levels (mean and 95% CI, from fully
adjusted regression model) by deciles of PFOA (A,C,E) and PFOS (B,D,F) concentrations, given the mean
values of the other covariates. Graph pairs are on the same scale.

distributed across water districts (chi-square
test, p = 0.172) and had significantly higher
PFOA and PFOS serum concentrations
compared with those with normal ALT val
ues (PFOA: 106.8 vs. 84.6 IU/L, p < 0.001;
PFOS: 24.3 vs. 23.3 IU/L, p < 0.001). No
interaction between PFOA/PFOS deciles with
fasting status was observed (p-values 0.816 and
0.387, r espectively).
The association between ln-GGT and
ln-PFOA reached a significant level in the fully
adjusted model (model 3; coefficient, 0.015;
95% CI: 0.010, 0.019) mainly due to the con
tribution of insulin resistance and BMI, which
appeared to be highly associated with ln-GGT
(Table 2); fitted values of GGT by deciles of
PFOA showed an apparent positive associa
tion (Figure 1C), although it was less clear than
that shown for ALT. The suggested association
with PFOA, however, was not confirmed in
the logistic regression model, in which no trend
across deciles was observed (p = 0.213), or for
the linear ln-units of PFOA values (OR = 1.01;
95% CI: 0.99, 1.04; Table 3). For PFOS, there
was some evidence of a slight inverse associa
tion with GGT in the minimally adjusted lin
ear regression model (model 1), which was
lost after adjusting for additional confound
ers (model 3; Table 2). The logistic regression
by deciles of PFOS suggested a weak negative
trend across deciles, although all ORs were close
to 1, and no overall association with ln-PFOS
was observed (Table 3). Overall, fitted values of
GGT were unchanged across deciles of PFOS
(Figure 1D). Subjects with abnormally high
GGT values were more frequent in one district
(chi-square test, p = 0.062) and had significantly
higher PFOA serum concentrations (93.7 vs.
86.1 IU/L, p = 0.004) but not PFOS serum
concentrations (23.5 vs. 23.4 IU/L, p = 0.499).
For direct bilirubin, there was a suggestion
of an inverse U-shaped relationship with PFOA,
with increasing levels of bilirubin per increas
ing levels of PFOA at low PFOA levels, and
decreasing bilirubin levels for concentrations
of PFOA above about 40 ng/mL (Figure 1E).
Overall, the linear regression relationship failed

Table 3. Logistic regression ORa (95% CI) of having abnormal high values of ALT, GGT, or direct bilirubin across deciles of PFOA and PFOS.
Decile
PFOA
Decile 1
Decile 2
Decile 3
Decile 4
Decile 5
Decile 6
Decile 7
Decile 8
Decile 9
Decile 10
Trendb
ln-Unitc
p-Valuec

ALT

GGT

Direct bilirubin

Reference
1.09 (0.94, 1.26)
1.19 (1.03, 1.37)
1.26 (1.09, 1.45)
1.40 (1.22, 1.62)
1.39 (1.21, 1.60)
1.31 (1.14, 1.52)
1.42 (1.23, 1.64)
1.40 (1.21, 1.62)
1.54 (1.33, 1.78)
< 0.001
1.10 (1.07, 1.13)
< 0.001

Reference
1.06 (0.93, 1.21)
1.07 (0.94, 1.21)
1.05 (0.93, 1.20)
1.11 (0.97, 1.26)
1.10 (0.96, 1.25)
1.20 (1.06, 1.37)
1.13 (0.99, 1.29)
1.06 (0.93, 1.22)
1.06 (0.92, 1.20)
0.213
1.01 (0.99, 1.04)
0.298

Reference
1.01 (0.66, 1.54)
1.04 (0.69, 1.56)
0.95 (0.62, 1.44)
0.89 (0.58, 1.37)
1.03 (0.68, 1.56)
0.86 (0.56, 1.32)
0.95 (0.62, 1.45)
0.80 (0.52, 1.25)
1.01 (0.66, 1.53)
0.496
0.97 (0.90, 1.05)
0.512

Decile
PFOS
Decile 1
Decile 2
Decile 3
Decile 4
Decile 5
Decile 6
Decile 7
Decile 8
Decile 9
Decile 10
Trendb
ln-unitc
p-Valuec

ALT

GGT

Direct bilirubin

Reference
1.01 (0.87, 1.16)
1.06 (0.91, 1.22)
1.11 (0.96, 1.28)
1.19 (1.04, 1.37)
1.19 (1.04, 1.37)
1.20 (1.04, 1.38)
1.24 (1.08, 1.43)
1.18 (1.02, 1.36)
1.25 (1.08, 1.44)
< 0.001
1.13 (1.07, 1.18)
< 0.001

Reference
1.06 (0.94, 1.20)
0.95 (0.83, 1.07)
0.93 (0.82, 1.06)
0.96 (0.84, 1.09)
1.03 (0.91, 1.17)
0.97 (0.85, 1.10)
0.91 (0.80, 1.04)
0.89 (0.78, 1.01)
0.94 (0.83, 1.07)
0.047
0.98 (0.94, 1.02)
0.310

Reference
0.75 (0.47, 1.20)
0.62 (0.39, 1.01)
0.72 (0.46, 1.13)
0.85 (0.55, 1.31)
0.95 (0.63, 1.44)
1.01 (0.67, 1.52)
0.93 (0.61, 1.41)
0.91 (0.60, 1.39)
1.23 (0.82, 1.83)
0.015
1.11 (0.96, 1.28)
0.168

aAdjusted

by age, sex, alcohol consumption, socioeconomic status, fasting status, month of blood sample collection, smoking, BMI, physical activity, increased serum iron, and insulin
resistance. bp-Value for trend across deciles. cOR and relative 95% CI and p-value for ln-PFOA/PFOS.
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to show any association in the adjusted model
(Table 2), and the likelihood ratio test after
introducing the quadratic term was statistically
significant (p < 0.001). In accordance, no pat
tern was evident in the logistic regression mod
els of high bilirubin (Table 3). By contrast, for
PFOS, a clear positive association was shown
in linear regression models for direct biliru
bin (coefficient, 0.029; 95% CI: 0.024, 0.034;
Table 2, Figure 1F), although this was not evi
dent in logistic regression models (Table 3).
However, logistic regression results for direct
bilirubin should be interpreted cautiously
because only 1.1% of the whole sample had
high levels and CIs were wide.
Multilevel analysis was restricted to subjects
living in water districts supplied by contami
nated water (n = 26,777) and excluding those
with private wells. The fitted values for each of
the outcomes of ALT, GGT, and direct bili
rubin versus mean PFOA serum level for the
six water districts are graphed in Figure 2. In
Table 4, the regression coefficients per ln-unit
of PFOA for a model between water districts
comparing district averages of ln-PFOA (B)
and for a model within water districts com
paring differences from the average (W) are
presented. There was a significant difference
between the between- and within-district com
ponents (p-value B/WΔ) for ALT and direct
bilirubin; however, each outcome showed dif
ferent patterns. The between-water-district
regression coefficient from linear regression of
ln-PFOA and ALT (0.010; 95% CI: –0.001,
0.020) was lower than the within-water-district
coefficient (0.027; 95% CI: 0.022, 0.031).
However, both coefficients were significant
or borderline significant, in the same direc
tion, and consistent with a positive associa
tion between ALT and PFOA levels. Although
the regression coefficient for the association
between GGT and ln-PFOA within water dis
trict was positive and significant (0.016; 95%
CI: 0.010, 0.023), this association was not sig
nificant in the between-water-district analysis
(0.005; 95% CI: –0.009, 0.018); the p-value
for interaction between/within water district
was not significant (p = 0.108). Conversely,
there was a significant inverse relationship

between ln-PFOA and direct bilirubin between
water districts (–0.013; 95% CI: –0.022,
–0.005) but not within water districts (0.0001;
95% CI: –0.004, 0.004).

Discussion
These results show a positive association
between PFOA and PFOS concentrations and
ALT serum levels, a marker of hepatocellular
damage. The linear association, consistently
replicated in all analyses, showed a monotonic
increase in logistic regression. Furthermore, the
presence of a consistent relationship in regres
sion analysis both between water districts and
among individuals within districts increases
strength of evidence for causal association. The
proportion of laboratory abnormal values rises
in relation to PFOA, but the small amount
of variation in outcomes explained by PFOA
(partial R2 ≤ 0.1%) suggests caution.
The observed associations between PFOA
or PFOS and ALT are generally consistent in
terms of direction and magnitude with previ
ous findings of occupational studies. A crosssectional study of 1,025 workers at the same
plant leading to the C8 Health Project reported
an association between PFOA and ALT levels
with a similar coefficient (mean ± SE coeffi
cient of log-transformed values, 0.023 ± 0.015;
p = 0.124). A significant linear regression coef
ficient between log-transformed–PFOA and
log-ALT (coefficient, 0.025 ± 0.013; p = 0.006)
was described in a cross-sectional occupational
surveillance conducted in three 3M plants in
the United States and Belgium (Olsen and
Zobel 2007). A small occupational study con
ducted in Italy showed a significant positive
association between PFOA and ALT levels
among workers exposed to PFOA (coefficient,
0.116; 95% CI: 0.054, 0.177; p < 0.01) (Costa

Table 4. Multilevel analysis of PFOA between and within district effects.
Coefficient between districts
(95% CI)

Liver function biomarker
ln-PFOA
ALT
GGT
Direct bilirubin
ap-Value

24

0.010 (–0.001, 0.020)#
0.005 (–0.009, 0.018)
–0.013 (–0.022, –005)*

26

22

p-Valuea

0.027 (0.022, 0.031)**
0.016 (0.010, 0.023)**
0.0001 (–0.004, 0.004)

0.003
0.108
0.004

0.112

Direct bilirubin (mg/dL)

GGT (IU/L)

23

Coefficient within districts
(95% CI)

testing the null hypothesis of no difference between and within water district. *p < 0.05. **p < 0.001. #p = 0.062.

25

ALT (IU/L)

et al. 2009). Notably, these results are also
consistent with data coming from a general
population survey (mean ± SE linear regression
coefficients with ALT: PFOA, 1.86 ± 0.62,
p = 0.005; PFOS, 1.01 ± 0.53, p = 0.066)
where background concentrations of PFOA are
much lower than those reported here (Lin et al.
2010). Only one previous study of this same
population reported no association with ALT
(regression coefficient = –0.00416, p = 0.65);
however, the observation was based on a much
smaller sample (most of whom were likely to
be included in the present analysis) and based
on figures coming from models including nonlog-transformed exposure or outcome variables
(Emmett et al. 2006).
Evidence for an association between PFOA
and PFOS and GGT is not so clear. Although
there was some suggestion of an association
in the linear regression models with PFOA, it
was not replicated in logistic regression models.
The instability of linear regression coefficients
(which are very sensitive to the inclusion of
additional covariates) might be due to a con
founding effect of diet, or residual confound
ing of alcohol consumption, which causes a
direct increase of GGT. Finally, the absence of
any trend across districts—even though there
are large contrasts in between-district mean
exposures—might be indicative of some con
founding factor acting at the individual level.
As shown recently, GGT levels are positively
associated with alcohol and meat intake after
adjusting for all potential nondietary confound
ers (Lee et al. 2004). To support this, there is
indirect evidence from an occupational study
that reported a significant association between
ln-GGT and ln-PFOA in models adjusted by
ln-age, ln-BMI, and ln-alcohol (mean ± SE coef
ficient, 0.033 ± 0.017, p = 0.05), which drops if
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Figure 2. Fitted values of ALT (A), GGT (B), and direct bilirubin (C) levels (mean and 95% CI; from fully adjusted regression model) by mean PFOA concentration in
the water district, given the mean values of the other covariates.
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BMI is replaced by ln-tryglicerides (a proxy for
diet) in the model (coefficient, 0.010 ± 0.016,
p = 0.55) (Olsen and Zobel 2007).
PFOA concentration has a positive asso
ciation with direct bilirubin up to 40 ng/mL,
followed by a decrease of bilirubin levels after
this peak. A negative association between
PFOA or PFOS and direct bilirubin has been
observed in some occupational studies (Costa
et al. 2009; Olsen and Zobel 2007; Sakr
et al. 2007b), which might be because they
used mainly subjects in the higher range of
exposure, missing the first part of an inverse
U-shaped curve. The figures of the betweendistrict comparison might reflect the fact that
the means of the four highest districts are well
above the value of 30 ng/mL and may account
for a larger portion of the observed association
above that value, or this may be evidence of
some geographic confounding.
The hepatotoxic effect of PFOA in rodents
leading to liver enlargement and altered hepato
cyte histology (Qazi et al. 2010) appears to be
mediated in part by PPAR-α agonism, lead
ing to altered expression of the genes involved
in peroxisome proliferation, cell cycle control,
and apoptosis (Lau et al. 2007). Although dif
ferent mechanisms also play a role in humans
(Bjork et al. 2011), human cellular responses do
predict a PPAR-α response (Rakhshandehroo
et al. 2009; Yang et al. 2008). In the human
population data presented here, the association
of PFOS concentration with increasing trans
aminase is almost as prominent as the associa
tion for PFOA, and human laboratory cell data
indicate relatively lower response of liver cells to
PFOS than to PFOA (Wolf et al. 2008).
The consistency and significance of asso
ciations of ALT end points outside the normal
range with PFOA serum concentration suggest
a true association with an underlying hepato
toxic effect in humans. However, only a small
proportion of end points fell outside the normal
value range, making the observed results more
difficult to interpret in terms of human health
risk. In particular, it is not clear if this small
increase in ALT levels can lead to clinically diag
nosable conditions in the future, or if this effect
is reversible (i.e., if it is reduced after removal of
the exposure to PFOA). Finally, results coming
from this study need to be read in the context
of health effect of PFAAs on humans, but data
cannot be directly used for estimating singlesubject damage in relation to exposure.
The main limitation of the present study is
the cross-sectional design, which makes causal
inference particularly difficult. However,
the consistency of the findings with previ
ous literature—in particular the association
with ALT—reinforces the hypothesis of a true
association. Also, self-reported data of lifestyle
characteristics being strongly associated with
the exposures of interest can hamper a correct
adjustment for potential confounders, which
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might be of particular relevance given the
small magnitude of the observed associations.
However, this study is the largest reported
so far on this topic on a population-based
sample of residents exposed to relatively high
concentrations of PFOA.

Conclusions
A small but clear linear association between
PFOA and PFOS serum concentrations and
ALT, a marker of hepatocellular injury, was
observed in this large population-based sam
ple of individuals with exposure to PFAAs.
These results are consistent with previous
findings and warrant further investigation,
in particular on the potential health conse
quence of long-term exposure and potential
accumulation of damage.
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